Skip to content

XOMA Corporation XOMA Free cash flow margin

Free cash flow margin at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
44.8%+16.8pp
Theravance Biopharma logo
Theravance BiopharmaTBPH
221.9%+206pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
54.1%+5.3pp
Zymeworks logo
ZymeworksZYME
-94.8%+15.5pp
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-75.1%+10.7pp
ALN
Alnylam PharmaceuticalsALNY
15%+12.7pp

Other financials

Income statement

See full
Revenue$12.3M-22.6%
Operating income-$480.0K-108%
Net income$4.5M+88.6%
EPS (diluted)$0.17+183%

Balance sheet

See full
Cash & equivalents$85.6M-5.2%
Total debt$124.7M+9.0%
Total equity$92.9M+9.7%
Total assets$271.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M+178%
CapEx$3.0K-29.4%
Free cash flow-$2.9M+36.0%

Valuation

See full
Market cap$745.16M+159%
Enterprise value$784.29M+151%
P/E22×
P/S15.4×+8.6×

Profitability

See full
Operating margin10.2%+5.5pp
Net margin69.6%+64.0pp

Returns & leverage

See full
Return on equity38.1%+35.2pp
Debt / equity1.3×0.0×
Current ratio3.6×-2.0×

Where this comes from

Calculated from XOMA Corporation’s reported figures.

Based on trailing twelve months.

The official record: XOMA Corporation’s 10-Q, filed May 9, 2024, on SEC EDGAR. View the filing →

Ask your AI about XOMA Corporation's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is XOMA Corporation's free cash flow margin?
XOMA Corporation (XOMA) reported free cash flow margin of -320% in Q1 2024.
How has XOMA Corporation's free cash flow margin changed year-over-year?
XOMA Corporation's free cash flow margin increased by 58.1% year-over-year, from -763.7% to -320%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.